Genmab A/S (Germany) Technical Analysis
| GE9 Stock | EUR 274.90 0.50 0.18% |
As of the 1st of February, Genmab A/S retains the Risk Adjusted Performance of 0.074, market risk adjusted performance of 0.4835, and Downside Deviation of 2.14. Genmab A/S technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Genmab A/S standard deviation, information ratio, treynor ratio, as well as the relationship between the variance and jensen alpha to decide if Genmab A/S is priced fairly, providing market reflects its last-minute price of 274.9 per share.
Genmab A/S Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Genmab, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GenmabGenmab |
Genmab A/S 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genmab A/S's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genmab A/S.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Genmab A/S on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Genmab AS or generate 0.0% return on investment in Genmab A/S over 90 days. Genmab A/S is related to or competes with BioNTech. Genmab AS, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark More
Genmab A/S Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genmab A/S's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genmab AS upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.14 | |||
| Information Ratio | 0.0718 | |||
| Maximum Drawdown | 9.52 | |||
| Value At Risk | (3.25) | |||
| Potential Upside | 4.48 |
Genmab A/S Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genmab A/S's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genmab A/S's standard deviation. In reality, there are many statistical measures that can use Genmab A/S historical prices to predict the future Genmab A/S's volatility.| Risk Adjusted Performance | 0.074 | |||
| Jensen Alpha | 0.1713 | |||
| Total Risk Alpha | 0.084 | |||
| Sortino Ratio | 0.0702 | |||
| Treynor Ratio | 0.4735 |
Genmab A/S February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.074 | |||
| Market Risk Adjusted Performance | 0.4835 | |||
| Mean Deviation | 1.56 | |||
| Semi Deviation | 1.7 | |||
| Downside Deviation | 2.14 | |||
| Coefficient Of Variation | 1071.38 | |||
| Standard Deviation | 2.09 | |||
| Variance | 4.36 | |||
| Information Ratio | 0.0718 | |||
| Jensen Alpha | 0.1713 | |||
| Total Risk Alpha | 0.084 | |||
| Sortino Ratio | 0.0702 | |||
| Treynor Ratio | 0.4735 | |||
| Maximum Drawdown | 9.52 | |||
| Value At Risk | (3.25) | |||
| Potential Upside | 4.48 | |||
| Downside Variance | 4.56 | |||
| Semi Variance | 2.89 | |||
| Expected Short fall | (1.67) | |||
| Skewness | 0.2674 | |||
| Kurtosis | 0.4395 |
Genmab A/S Backtested Returns
Genmab A/S appears to be very steady, given 3 months investment horizon. Genmab A/S holds Efficiency (Sharpe) Ratio of 0.0933, which attests that the entity had a 0.0933 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Genmab A/S, which you can use to evaluate the volatility of the firm. Please utilize Genmab A/S's Downside Deviation of 2.14, risk adjusted performance of 0.074, and Market Risk Adjusted Performance of 0.4835 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Genmab A/S holds a performance score of 7. The company retains a Market Volatility (i.e., Beta) of 0.39, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genmab A/S's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genmab A/S is expected to be smaller as well. Please check Genmab A/S's information ratio, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Genmab A/S's current trending patterns will revert.
Auto-correlation | 0.05 |
Virtually no predictability
Genmab AS has virtually no predictability. Overlapping area represents the amount of predictability between Genmab A/S time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genmab A/S price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Genmab A/S price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | 0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 71.76 |
Genmab A/S technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Genmab A/S Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Genmab A/S volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Genmab A/S Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Genmab AS on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Genmab AS based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Genmab A/S price pattern first instead of the macroeconomic environment surrounding Genmab A/S. By analyzing Genmab A/S's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Genmab A/S's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Genmab A/S specific price patterns or momentum indicators. Please read more on our technical analysis page.
Genmab A/S February 1, 2026 Technical Indicators
Most technical analysis of Genmab help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Genmab from various momentum indicators to cycle indicators. When you analyze Genmab charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.074 | |||
| Market Risk Adjusted Performance | 0.4835 | |||
| Mean Deviation | 1.56 | |||
| Semi Deviation | 1.7 | |||
| Downside Deviation | 2.14 | |||
| Coefficient Of Variation | 1071.38 | |||
| Standard Deviation | 2.09 | |||
| Variance | 4.36 | |||
| Information Ratio | 0.0718 | |||
| Jensen Alpha | 0.1713 | |||
| Total Risk Alpha | 0.084 | |||
| Sortino Ratio | 0.0702 | |||
| Treynor Ratio | 0.4735 | |||
| Maximum Drawdown | 9.52 | |||
| Value At Risk | (3.25) | |||
| Potential Upside | 4.48 | |||
| Downside Variance | 4.56 | |||
| Semi Variance | 2.89 | |||
| Expected Short fall | (1.67) | |||
| Skewness | 0.2674 | |||
| Kurtosis | 0.4395 |
Genmab A/S February 1, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Genmab stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 274.90 | ||
| Day Typical Price | 274.90 | ||
| Price Action Indicator | (0.25) |
Complementary Tools for Genmab Stock analysis
When running Genmab A/S's price analysis, check to measure Genmab A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab A/S is operating at the current time. Most of Genmab A/S's value examination focuses on studying past and present price action to predict the probability of Genmab A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab A/S's price. Additionally, you may evaluate how the addition of Genmab A/S to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |